Selim Corbacioglu Selected Research

heparanase

4/2023

Heparanase wildtype is associated with a reduced incidence of transplant-associated systemic vasculopathies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Selim Corbacioglu Research Topics

Disease

16	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 05/2023 - 04/2012
15	Neoplasms (Cancer) 04/2023 - 04/2012
12	Sickle Cell Anemia (Hemoglobin S Disease) 10/2023 - 01/2019
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 05/2003
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 04/2003
6	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2021 - 12/2009
4	Thalassemia 02/2024 - 01/2020
4	Communicable Diseases (Infectious Diseases) 01/2023 - 01/2020
4	COVID-19 01/2023 - 11/2020
3	Aplastic Anemia (Anemia, Hypoplastic) 03/2024 - 10/2019
3	Immune System Diseases (Immune Disorders) 01/2023 - 10/2019
3	Acute Lung Injury 01/2022 - 01/2020
3	Leukemia 01/2022 - 01/2015
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 10/2020
3	Sepsis (Septicemia) 01/2022 - 01/2020
2	Iron Overload 12/2023 - 01/2020
2	Neuroblastoma 03/2023 - 01/2021
2	Carcinoma (Carcinomatosis) 01/2023 - 08/2015
2	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 12/2022 - 08/2015
2	beta-Thalassemia (Cooley's Anemia) 03/2022 - 01/2019
2	Infections 01/2022 - 01/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2021
2	Pathologic Complete Response 01/2021 - 04/2012
2	Hyperbilirubinemia 01/2020 - 05/2003
2	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2020 - 10/2019
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2009 - 05/2003
1	Primary Myelofibrosis (Myelosclerosis) 04/2024
1	Congenital Bone Marrow Failure Syndromes 03/2024
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 02/2024
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2024
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2024
1	Sickle Cell Trait 11/2023
1	Stomatitis 05/2023
1	Inflammation (Inflammations) 04/2023
1	Neoplasm Metastasis (Metastasis) 04/2023
1	Cough 01/2023
1	Fever (Fevers) 01/2023
1	Thrombotic Microangiopathies 01/2023
1	Coinfection 01/2023
1	Neutropenia 01/2022
1	Necrosis 01/2022
1	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 12/2021
1	Bone Marrow Failure Disorders 01/2021
1	Fanconi Anemia (Fanconi's Anemia) 01/2021
1	Hemolysis 01/2021
1	Pure Red-Cell Aplasia 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2020
1	Juvenile Myelomonocytic Leukemia 10/2020
1	cell-associated neurotoxicity 01/2020

Drug/Important Bio-Agent (IBA)

12	defibrotideIBA 05/2023 - 04/2012
5	treosulfanIBA 02/2024 - 10/2020
5	Busulfan (Busulfex)FDA Link 02/2024 - 01/2021
5	fludarabineIBA 02/2024 - 10/2020
3	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 02/2024 - 10/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 01/2021
2	Monoclonal AntibodiesIBA 01/2023 - 04/2003
2	AntigensIBA 01/2021 - 01/2020
2	Sirolimus (Rapamycin)FDA Link 01/2021 - 02/2015
2	Gemtuzumab (Mylotarg)FDA Link 01/2020 - 05/2003
2	Temozolomide (Temodar)FDA LinkGeneric 01/2017 - 02/2015
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2023
1	heparanaseIBA 04/2023
1	EnzymesIBA 04/2023
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 03/2023
1	eculizumab FDA Link 01/2023
1	C-Reactive ProteinIBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Adenosine Monophosphate (AMP)IBA 06/2022
1	Starch (Cornstarch)IBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	GelatinIBA 01/2022
1	TransferasesIBA 01/2022
1	O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	HLA-A Antigens (HLA-A)IBA 10/2021
1	HLA-B Antigens (HLA-B)IBA 10/2021
1	Protein Sorting Signals (Signal Peptide)IBA 10/2021
1	1- (4- (4- (1- cyclopropylsulfonylcyclopropyl)- 6- (3- methylmorpholin- 4- yl)pyrimidin- 2- yl)phenyl)- 3- (2- hydroxyethyl)thioureaIBA 01/2021
1	PP242IBA 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Hemagglutinins (Hemagglutinin)IBA 01/2021
1	ParaffinIBA 01/2020
1	Penicillins (Penicillin)FDA Link 01/2020

Therapy/Procedure

29	Hematopoietic Stem Cell Transplantation 02/2024 - 12/2009
18	Cell Transplantation 04/2024 - 06/2016
16	Transplantation 04/2024 - 01/2018
15	Stem Cell Transplantation 03/2024 - 04/2003
12	Therapeutics 01/2023 - 08/2012
9	Drug Therapy (Chemotherapy) 03/2023 - 11/2011
3	Critical Care (Surgical Intensive Care) 01/2022 - 01/2020
3	Immunotherapy 01/2022 - 01/2021
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2024 - 01/2021
2	Haploidentical Transplantation 01/2024 - 01/2021
2	Donor Selection 12/2021 - 01/2021
1	Erythrocyte Transfusion 12/2023
1	Combined Modality Therapy 03/2023
1	Neonatal Intensive Care 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Extracorporeal Membrane Oxygenation 01/2022
1	Parenteral Nutrition 01/2020